Table 2.

TG and thrombin dynamics parameters in APS patients with and without prior thrombosis and without anticoagulant therapy

ParameterNo thrombosisThrombosisP
TG 1 pM TF    
 Lag time, min 4.0 (4.0) 4.0 (2.3) NS 
 Time to peak, min 8.0 (4.0) 8.0 (2.3) NS 
 Peak, nM 238 (133) 284 (93) NS 
 ETP, nM × min 1131 (212) 1365 (545) .003 
Prothrombin conversion 1 pM TF    
 Total prothrombin converted, nM 1050 (350) 1313 (532) NS 
 Maximum prothrombin conversion rate, nM/min 397 (365) 480 (173) NS 
TG 5 pM TF    
 Lag time, min 2.0 (1.0) 2.0 (1.3) NS 
 Time to peak, min 4.0 (2.0) 3.0 (2.0) NS 
 Peak, nM 340 (58) 395 (125) .026 
 ETP, nM × min 1130 (145) 1410 (740) .001 
 Inhibition of peak by TM, % 11.0 (9.0) 5.5 (9.5) .048 
Prothrombin conversion 5 pM TF    
 Total prothrombin converted, nM 1149 (384) 1355 (702) .023 
 Maximum prothrombin conversion rate, nM/min 895 (390) 999 (421) .041 
 Inhibition of maximum prothrombin conversion rate by TM, % 10.2 (20.4) 6.5 (3.0) NS 
Thrombin decay capacity, min−1 0.72 (0.28) 0.65 (0.17) NS 
ParameterNo thrombosisThrombosisP
TG 1 pM TF    
 Lag time, min 4.0 (4.0) 4.0 (2.3) NS 
 Time to peak, min 8.0 (4.0) 8.0 (2.3) NS 
 Peak, nM 238 (133) 284 (93) NS 
 ETP, nM × min 1131 (212) 1365 (545) .003 
Prothrombin conversion 1 pM TF    
 Total prothrombin converted, nM 1050 (350) 1313 (532) NS 
 Maximum prothrombin conversion rate, nM/min 397 (365) 480 (173) NS 
TG 5 pM TF    
 Lag time, min 2.0 (1.0) 2.0 (1.3) NS 
 Time to peak, min 4.0 (2.0) 3.0 (2.0) NS 
 Peak, nM 340 (58) 395 (125) .026 
 ETP, nM × min 1130 (145) 1410 (740) .001 
 Inhibition of peak by TM, % 11.0 (9.0) 5.5 (9.5) .048 
Prothrombin conversion 5 pM TF    
 Total prothrombin converted, nM 1149 (384) 1355 (702) .023 
 Maximum prothrombin conversion rate, nM/min 895 (390) 999 (421) .041 
 Inhibition of maximum prothrombin conversion rate by TM, % 10.2 (20.4) 6.5 (3.0) NS 
Thrombin decay capacity, min−1 0.72 (0.28) 0.65 (0.17) NS 

NS, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal